World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 4 May 2015
Main ID:  NCT02426320
Date of registration: 21/04/2015
Prospective Registration: No
Primary sponsor: Davinia Withington
Public title: Pilot Study for Sedation Interruption in Children
Scientific title: Daily Interruption of Sedative Infusions in Mechanically Ventilated Children: A Randomized Pilot Study
Date of first enrolment: April 2015
Target sample size: 30
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02426320
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care  
Phase:  N/A
Countries of recruitment
Canada
Contacts
Name:     Conall Francoeur
Address: 
Telephone:
Email:
Affiliation:  McGill University Health Center
Name:     Christina Maratta
Address: 
Telephone:
Email:
Affiliation:  McGill University Health Center
Name:     Maryse Dagenais
Address: 
Telephone:
Email:
Affiliation:  McGill University Health Center
Name:     Yasser Kazzaz, MBBS, FRCPC, FAAP
Address: 
Telephone: 6479892770
Email: yasser.md@gmail.com
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Intubated and mechanically ventilated patients due to respiratory failure of multiple
etiologies or after major surgical procedures for more than 24 hours.

- Sedation managed by benzodiazepines and opioids infusions

Exclusion Criteria:

- If sedation is required as part of medical management (Pulmonary hypertension,
Increase intracranial pressure, Seizures

- Trauma & burn admissions

- Patients resuscitated from cardiac arrest

- Allergy to sedation (midazolam)

- Allergy to analgesia (fentanyl, morphine)

- Difficult airway including post-operative airway surgeries. (As deemed by ICU
physician in charge)

- High frequency oscillator

- Special gas as inhaled nitric oxide, or isoflurane.

- Chronic ventilatory support

- Neuromuscular diseases

- Corrected Gestational age less than 37 weeks.

- Patients not expected to survive to discharge as per attending physician.

- Palliative care patients.



Age minimum: N/A
Age maximum: 18 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Sedation
Sedation Protocols
Daily Sedative Interruption
Mechanical Ventilation
Sedation Strategies
Intervention(s)
Other: Standard Sedation Protocol
Other: Sedation Interruption Protocol
Primary Outcome(s)
Duration of mechanical ventilation in hours. [Time Frame: intraoperative]
Reasons for non-participation [Time Frame: At 30 days]
Recruitment rate [Time Frame: At 30 days]
Adherence Rate [Time Frame: At 30 days]
Secondary Outcome(s)
Secondary ID(s)
14-011-PED
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history